XLO
Xilio Therapeutics, Inc. · Healthcare
Gilead Sciences, Inc. bought $1.8M of Xilio Therapeutics, Inc.
10% owner
Bought$1,830,377
$1.04Price
1,759,978Shares
+24%Stake
What XLO did for a copier
- $1,000 copied at Fri, Dec 20 open, $14.84
- $651
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Feb 6 close.
Gilead Sciences, Inc.'s record
6 other buys with 3 months of prices since 2023: on average −30.2% against the S&P 500, and 0 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 18. Filed Thu, Dec 19, 4:19 PM ET, after the close. Returns use the Dec 20 open and the Feb 6 close. Not investment advice.